Cytimmune Sciences, Inc. (Cytimmune)

Oncology Corporate Profile

HQ Location

15010 Broschart Road, Suite 270
ROckville, MD 20850

Company Description

CytImmune Sciences is a clinical stage nanomedicine company with a core focus on the discovery, development and commercialization of multifunctional, tumor-targeted therapies. Based on an R&D strategy which harnesses the unique properties of gold nanoparticles, cytotoxic agents, and biology of tumors, the Company is developing a pipeline of proprietary drug candidates binding potent anti-cancer agents -- whose toxicity profiles currently prevent or severely limit clinical use -- to its patented colloidal gold tumor-targeting nanotechnology.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
CYT-6091NanomedicineNon Small Cell Lung Cancer (NSCLC)II

View additional information on product candidates here »


Recent News Headlines

There are no news items to display